Research ExplorerJournalsEUR J CANCER Publications

EUR J CANCER - European journal of cancer (Oxford, England : 1990)

51 - 100 out of 144Page size: 50

Publications

  1. 2018

  2. Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis

    Pelzer, U., Wislocka, L., Jühling, A., Striefler, J., Klein, F., Roemmler-Zehrer, J., Sinn, M., Denecke, T., Bahra, M. & Riess, H., 09.2018, In: EUR J CANCER. 100, p. 85-93 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors

    Seidel, C., Daugaard, G., Tryakin, A., Necchi, A., Cohn Cedermark, G., Ståhl, O., Hentrich, M., Brito, M., Albany, C., Taza, F., Gerl, A., Oechsle, K. & Bokemeyer, C., 05.2018, In: EUR J CANCER. 94, p. 16-25 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study

    Vogel, A., Kasper, S., Bitzer, M., Block, A., Sinn, M., Schulze-Bergkamen, H., Moehler, M., Pfarr, N., Endris, V., Goeppert, B., Merx, K., Schnoy, E., Siveke, J. T., Michl, P., Waldschmidt, D., Kuhlmann, J., Geissler, M., Kahl, C., Evenkamp, R., Schmidt, T., Kuhlmann, A., Weichert, W. & Kubicka, S., 03.2018, In: EUR J CANCER. 92, p. 11-19 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2017

  6. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study

    Pivot, X., Verma, S., Fallowfield, L., Müller, V., Lichinitser, M., Jenkins, V., Sánchez Muñoz, A., Machackova, Z., Osborne, S., Gligorov, J. & PrefHer Study Group, 11.2017, In: EUR J CANCER. 86, p. 82-90 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma

    Lohneis, P., Sinn, M., Bischoff, S., Jühling, A., Pelzer, U., Wislocka, L., Bahra, M., Sinn, B. V., Denkert, C., Oettle, H., Bläker, H., Riess, H., Jöhrens, K. & Striefler, J. K., 09.2017, In: EUR J CANCER. 83, p. 290-301 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Geographical variability in survival of European children with central nervous system tumours

    Gatta, G., Peris-Bonet, R., Visser, O., Stiller, C. A., Marcos-Gragera, R., Sánchez, M-J., Lacour, B., Kaatsch, P., Berrino, F., Rutkowski, S., Botta, L. & EUROCARE-5 Working Group, 09.2017, In: EUR J CANCER. 82, p. 137-148 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

    Gligorov, J., Ataseven, B., Verrill, M., De Laurentiis, M., Jung, K. H., Azim, H. A., Al-Sakaff, N., Lauer, S., Shing, M., Pivot, X. & SafeHer Study Group, 09.2017, In: EUR J CANCER. 82, p. 237-246 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. The risk of being depressed is significantly higher in cancer patients than in the general Population: Prevalence and severity of depressive symptoms across major cancer types

    Hartung, T. J., Brähler, E., Faller, H., Härter, M., Hinz, A., Johansen, C., Keller, M., Koch, U., Schulz, H., Weis, J. & Mehnert, A., 02.2017, In: EUR J CANCER. 72, p. 46-53 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2016

  12. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

    Heil, J., Schaefgen, B., Sinn, P., Richter, H., Harcos, A., Gomez, C., Stieber, A., Hennigs, A., Rauch, G., Schuetz, F., Sohn, C., Schneeweiss, A. & Golatta, M., 12.2016, In: EUR J CANCER. 69, p. 142-150 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study

    Woelber, L., Griebel, L-F., Eulenburg, C., Sehouli, J., Jueckstock, J., Hilpert, F., de Gregorio, N., Hasenburg, A., Ignatov, A., Hillemanns, P., Fuerst, S., Strauss, H-G., Baumann, K. H., Thiel, F. C., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L. C., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Richter, B., Neuser, P. & Mahner, S., 12.2016, In: EUR J CANCER. 69, p. 180-188 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology

    von Lilienfeld-Toal, M., Berger, A., Christopeit, M., Hentrich, M., Heussel, C. P., Kalkreuth, J., Klein, M., Kochanek, M., Penack, O., Hauf, E., Rieger, C., Silling, G., Vehreschild, M., Weber, T., Wolf, H-H., Lehners, N., Schalk, E. & Mayer, K., 11.2016, In: EUR J CANCER. 67, p. 200-212 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Corrigendum to "Borderline tumours of the ovary A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914]

    du Bois, A., Ewald-Riegler, N., de Gregorio, N., Reuss, A., Mahner, S., Fotopoulou, C., Kommoss, F., Schmalfeldt, B., Hilpert, F., Fehm, T., Burges, A., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H-G., Hellriegel, M., Wimberger, P., Keyver-Paik, M-D., Baumann, K., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schröder, W., Münstedt, K., Richter, B., Kommoss, S. & Hauptmann, S., 09.2016, In: EUR J CANCER. 65, p. 192-193 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  16. Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial

    Ignatiadis, M., Rack, B., Rothé, F., Riethdorf, S., Decraene, C., Bonnefoi, H., Dittrich, C., Messina, C., Beauvois, M., Trapp, E., Goulioti, T., Tryfonidis, K., Pantel, K., Repollet, M., Janni, W., Piccart, M., Sotiriou, C., Litiere, S. & Pierga, J-Y., 08.2016, In: EUR J CANCER. 63, p. 97-104 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation

    Merz, M., Jansen, L., Castro, F. A., Hillengass, J., Salwender, H., Weisel, K., Scheid, C., Luttmann, S., Emrich, K., Holleczek, B., Katalinic, A., Nennecke, A., Straka, C., Langer, C., Engelhardt, M., Einsele, H., Kröger, N., Beelen, D., Dreger, P., Brenner, H., Goldschmidt, H., GEKID cancer survival working group & German National Registry for Stem Cell Transplants (DRST), 07.2016, In: EUR J CANCER. 62, p. 1-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

    Fiedler, W., DeDosso, S., Cresta, S., Weidmann, J., Tessari, A., Salzberg, M., Dietrich, B., Baumeister, H., Goletz, S., Gianni, L. & Sessa, C., 07.06.2016, In: EUR J CANCER. 63, p. 55-63 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'

    Pompe, R. S., von Bueren, A. O., Mynarek, M., von Hoff, K. & Rutkowski, S., 03.2016, In: EUR J CANCER. 56, p. 181-2 2 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  20. 2015

  21. Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy

    Pompe, R. S., von Bueren, A. O., Mynarek, M., von Hoff, K., Friedrich, C., Kwiecien, R., Treulieb, W., Lindow, C., Deinlein, F., Fleischhack, G., Kuehl, J. & Rutkowski, S., 11.2015, In: EUR J CANCER. 51, 17, p. 2634-2642

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol

    von Bueren, A. O., Friedrich, C., von Hoff, K., Kwiecien, R., Müller, K., Pietsch, T., Warmuth-Metz, M., Hau, P., Benesch, M., Kuehl, J., Kortmann, R. D. & Rutkowski, S., 11.2015, In: EUR J CANCER. 51, 16, p. 2434-43 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial

    Sinn, M., Riess, H., Sinn, B. V., Stieler, J. M., Pelzer, U., Striefler, J. K., Oettle, H., Bahra, M., Denkert, C., Bläker, H. & Lohneis, P., 08.2015, In: EUR J CANCER. 51, 12, p. 1546-54 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer

    Bokemeyer, C., Köhne, C-H., Ciardiello, F., Lenz, H-J., Heinemann, V., Klinkhardt, U., Beier, F., Duecker, K., van Krieken, J. H. & Tejpar, S., 07.2015, In: EUR J CANCER. 51, 10, p. 1243-52 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence

    Tinhofer, I., Jöhrens, K., Keilholz, U., Kaufmann, A. M., Lehmann, A., Weichert, W., Stenzinger, A., Stromberger, C., Klinghammer, K., Becker, E-T., Dommerich, S., Stölzel, K., Hofmann, V. M., Hildebrandt, B., Moser, P. L., Ervens, J., Böttcher, A., Albers, A. E., Stabenow, R., Reinecke, A., Budach, V., Hoffmeister, B. & Raguse, J. D., 03.2015, In: EUR J CANCER. 51, 4, p. 514-21 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. 2014

  27. Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

    Moehler, M., Maderer, A., Schimanski, C., Kanzler, S., Denzer, U., Kolligs, F. T., Ebert, M. P., Distelrath, A., Geissler, M., Trojan, J., Schütz, M., Berie, L., Sauvigny, C., Lammert, F., Lohse, A., Dollinger, M. M., Lindig, U., Duerr, E. M., Lubomierski, N., Zimmermann, S., Wachtlin, D., Kaiser, A-K., Schadmand-Fischer, S., Galle, P. R., Woerns, M., Working Group of Internal Oncology & Denzer, U. W., 01.12.2014, In: EUR J CANCER. 50, 18, p. 3125-35 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis

    Hölscher, A. H., Bollschweiler, E., Bogoevski, D., Schmidt, H., Semrau, R. & Izbicki, J. R., 11.2014, In: EUR J CANCER. 50, 17, p. 2950-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy

    Gakis, G., Fritsche, H-M., Hassan, F., Kluth, L., Miller, F., Soave, A., Otto, W., Schwentner, C., Todenhöfer, T., Dahlem, R., Burger, M., Fisch, M., Stenzl, A., Aziz, A. & Rink, M., 01.10.2014, In: EUR J CANCER. 50, 15, p. 2583-2591 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients - A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

    Ruscito, I., Dimitrova, D., Vasconcelos, I., Gellhaus, K., Schwachula, T., Bellati, F., Zeillinger, R., Benedetti-Panici, P., Vergote, I., Mahner, S., Cacsire-Tong, D., Concin, N., Darb-Esfahani, S., Lambrechts, S., Sehouli, J., Olek, S. & Braicu, E. I., 01.08.2014, In: EUR J CANCER. 50, 12, p. 2090-2098

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Clinical management of epithelial ovarian cancer during pregnancy

    Grimm, D., Woelber, L., Trillsch, F., Keller-v. Amsberg, G. & Mahner, S., 01.03.2014, In: EUR J CANCER. 50, 5, p. 963-971 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions

    Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium

    Pils, D., Bachmayr-Heyda, A., Auer, K., Svoboda, M., Auner, V., Hager, G., Obermayr, E., Reiner, A., Reinthaller, A., Speiser, P., Braicu, I., Sehouli, J., Lambrechts, S., Vergote, I., Mahner, S., Berger, A., Cacsire Castillo-Tong, D. & Zeillinger, R., 01.01.2014, In: EUR J CANCER. 50, 1, p. 99-110 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Categories of response to first line vascular endothelial growth factor receptor targeted therapy and overall survival in patients with metastatic renal cell carcinoma

    Busch, J., Seidel, C., Goranova, I., Erber, B., Peters, R., Friedersdorff, F., Magheli, A., Miller, K., Grünwald, V. & Weikert, S., 2014, In: EUR J CANCER. 50, 3, p. 563-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2013

  36. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

    Hoffmann, J., Souchon, R., Lebeau, A., Öhlschlegel, C., Gruber, G., Rageth, C., Weber, W., Harbeck, N., Janni, W., Kreipe, H., Fitzal, F., Resch, A., Bago-Horvath, Z., Peintinger, F. & AGO, 01.07.2013, In: EUR J CANCER. 49, 10, p. 2277-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer

    Gannon, P. O., Lessard, L., Stevens, L-M., Forest, V., Bégin, L. R., Minner, S., Tennstedt, P., Schlomm, T., Mes-Masson, A-M. & Saad, F., 01.07.2013, In: EUR J CANCER. 49, 10, p. 2441-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group

    du Bois, A., Ewald-Riegler, N., de Gregorio, N., Reuss, A., Mahner, S., Fotopoulou, C., Kommoss, F., Schmalfeldt, B., Hilpert, F., Fehm, T., Burges, A., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H-G., Hellriegel, M., Wimberger, P., Keyver-Paik, M-D., Baumann, K., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schröder, W., Münstedt, K., Richter, B., Kommoss, S., Hauptmann, S. & Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group, 01.05.2013, In: EUR J CANCER. 49, 8, p. 1905-14 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy

    Xylinas, E., Rink, M., Robinson, B. D., Lotan, Y., Babjuk, M., Brisuda, A., Green, D. A., Kluth, L. A., Pycha, A., Fradet, Y., Faison, T., Lee, R. K., Karakiewicz, P. I., Zerbib, M., Scherr, D. S. & Shariat, S. F., 01.05.2013, In: EUR J CANCER. 49, 8, p. 1889-97 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

    Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 01.04.2013, In: EUR J CANCER. 49, 6, p. 1273-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.

    Eckert, C., von Stackelberg, A., Seeger, K., Groeneveld, T. W. L., Peters, C., Klingebiel, T., Borkhardt, A., Schrappe, M., Escherich, G. & Henze, G., 2013, In: EUR J CANCER. 49, 6, p. 1346-1355 10 p., 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials.

    Mahner, S., zu Eulenburg, C., Staehle, A., Wegscheider, K., Reuss, A., Pujade-Lauraine, E., Harter, P., Ray-Coquard, I., Pfisterer, J., du Bois, A., Arbeitsgemeinschaft Gynaekologisch & GINECO, 2013, In: EUR J CANCER. 49, 1, p. 142-149 8 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: a randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+).

    Al-Batran, S-E., Pauligk, C., Homann, N., Hartmann, J. T., Moehler, M., Probst, S., Rethwisch, V., Stoehlmacher-Williams, J., Prasnikar, N., Hollerbach, S., Bokemeyer, C., Mahlberg, R., Hofheinz, R. D., Luley, K., Kullmann, F. & Jäger, E., 2013, In: EUR J CANCER. 49, 4, p. 835-842 8 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study

    Friedrich, C., von Bueren, A. O., von Hoff, K., Kwiecien, R., Pietsch, T., Warmuth-Metz, M., Hau, P., Deinlein, F., Kuehl, J., Kortmann, R. D. & Rutkowski, S., 2013, In: EUR J CANCER. 49, 4, p. 893-903 11 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. 2012

  46. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials.

    Bokemeyer, C., Eric, V. C., Rougier, P., Ciardiello, F., Heeger, S., Schlichting, M., Celik, I. & Köhne, C-H., 01.07.2012, In: EUR J CANCER. 48, 10, p. 1466-1475 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.

    Gerber, N. U., von Hoff, K., von Bueren, A., Treulieb, W., Treulieb, W., Deinlein, F., Benesch, M., Zwiener, I., Soerensen, N., Warmuth-Metz, M., Pietsch, T., Mittler, U., Kuehl, J., Kortmann, R-D., Rutkowski, S. & Rutkowski, S., 2012, In: EUR J CANCER. 48, 13, p. 2028-2036 13.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.

    Sun, M., Abdollah, F., Bianchi, M., Trinh, Q-D., Shariat, S. F., Jeldres, C., Tian, Z., Hansen, J., Briganti, A., Graefen, M., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2012, In: EUR J CANCER. 48(10), p. 1503-1511

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma--a multicentre study.

    Steffens, S., Janssen, M., Roos, F. C., Becker, F., Schumacher, S., Seidel, C., Wegener, G., Thüroff, J. W., Hofmann, R., Stöckle, M., Siemer, S., Schrader, M., Hartmann, A., Kuczyk, M. A., Junker, K. & Schrader, A. J., 2012, In: EUR J CANCER. 48, 15, p. 2347-2352 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

    Karn, T., Pusztai, L., Ruckhäberle, E., Liedtke, C., Müller, V., Schmidt, M., Metzler, D., Wang, J., Coombes, K. R., Gätje, R., Hanker, L., Solbach, C., Ahr, A., Holtrich, U., Rody, A. & Kaufmann, M., 2012, In: EUR J CANCER. 48, 1, p. 12-23 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

    Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E. D., Taillibert, S., Liebermann, F., Dbalý, V., Ram, Z., Villano, J. L., Rainov, N., Weinberg, U., Schiff, D., Kunschner, L., Raizer, J., Honnorat, J., Sloan, A., Malkin, M., Landolfi, J. C., Payer, F., Mehdorn, M., Weil, R. J., Pannullo, S. C., Westphal, M., Smrcka, M., Chin, L., Kostron, H., Hofer, S., Bruce, J., Cosgrove, R., Paleologous, N., Palti, Y. & Gutin, P. H., 2012, In: EUR J CANCER. 48, 14, p. 2192-2202 14.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Progression free survival of first line vascular endothelial growth factor-targeted therapy is an important prognostic parameter in patients with metastatic renal cell carcinoma.

    Seidel, C., Busch, J., Weikert, S., Steffens, S., Fenner, M., Ganser, A. & Grünwald, V., 2012, In: EUR J CANCER. 48, 7, p. 1023-1030 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.

    Liedtke, C., Packeisen, J., Hess, K. R., Vogt, U., Kiesel, L., Kersting, C., Korsching, E., Brandt, B. & Buerger, H., 2012, In: EUR J CANCER. 48(13), p. 2066-2074

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 2011

  55. Brachyury expression predicts poor prognosis at early stages of colorectal cancer.

    Kilic, N., Feldhaus, S., Kilic, E., Tennstedt, P., Wicklein, D., Wasielewski, R. V., Viebahn, C., Kreipe, H. & Schumacher, U., 2011, In: EUR J CANCER. 47, 7, p. 1080-1085 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Clinical management of primary vulvar cancer.

    Wölber, L., Kock, L., Gieseking, F., Petersen, C., Trillsch, F., Choschzick, M., Jänicke, F. & Mahner, S., 2011, In: EUR J CANCER. 47, 15, p. 2315-2321 15.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Current standards and new trends in the primary treatment of colorectal cancer.

    Stein, A., Atanackovic, D. & Bokemeyer, C., 2011, In: EUR J CANCER. 47 Suppl 3, p. 312-314

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.

    von Stackelberg, A., Völzke, E., Kühl, J-S., Seeger, K., Schrauder, A., Escherich, G., Henze, G., Tallen, G. & Group, ALL-REZ. BFM. S., 2011, In: EUR J CANCER. 47, 1, p. 90-97 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next